Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Michael Walther. (2006) Advances in vaccine development against the pre-erythrocytic stage of Plasmodium falciparum malaria. Expert Review of Vaccines 5:1, pages 81-93.
Read now
Read now
Articles from other publishers (21)
Reysla Maria da Silveira Mariano, Ana Alice Maia Gonçalves, Diana Souza de Oliveira, Helen Silva Ribeiro, Diogo Fonseca Soares Pereira, Ingrid Soares Santos, Daniel Ferreira Lair, Augusto Ventura da Silva, Alexsandro Sobreira Galdino, Miguel Angel Chávez-Fumagalli, Denise da Silveira-Lemos, Walderez Ornelas Dutra & Rodolfo Cordeiro Giunchetti. (2023) A Review of Major Patents on Potential Malaria Vaccine Targets. Pathogens 12:2, pages 247.
Crossref
Crossref
François P. Roman, Margherita Coccia & Lode Schuerman. (2020) Commentary in reply to a publication on Plasmodium falciparum pre-erythrocytic stage vaccine development. Malaria Journal 19:1.
Crossref
Crossref
M.A. Avery, D.J. Weldon & K.M. Muraleedharan. 2016. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering. Reference Module in Chemistry, Molecular Sciences and Chemical Engineering.
Tobias O. Apinjoh, Rolland B. Tata, Judith K. Anchang-Kimbi, Hanesh F. Chi, Eleanor M. Fon, Regina N. Mugri, Delphine A. Tangoh, Robert V. Nyingchu, Stephen M. Ghogomu, Theresa Nkuo-Akenji & Eric A. Achidi. (2015) Plasmodium falciparum merozoite surface protein 1 block 2 gene polymorphism in field isolates along the slope of mount Cameroon: a cross – sectional study. BMC Infectious Diseases 15:1.
Crossref
Crossref
Alan R. Shaw & Mark B. Feinberg. 2013. Clinical Immunology. Clinical Immunology
1095
1121
.
Ana Cecilia Lopez, Andres Ortiz, Jorge Coello, Wilfredo Sosa-Ochoa, Rosa E Mejia Torres, Engels I Banegas, Irina Jovel & Gustavo A Fontecha. (2012) Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Honduras. Malaria Journal 11:1.
Crossref
Crossref
Satish Mishra, Urvashi Rai, Takayuki Shiratsuchi, Xiangming Li, Yannick Vanloubbeeck, Joe Cohen, Ruth S. Nussenzweig, Elizabeth A. Winzeler, Moriya Tsuji & Victor Nussenzweig. (2011) Identification of non-CSP antigens bearing CD8 epitopes in mice immunized with irradiated sporozoites. Vaccine 29:43, pages 7335-7342.
Crossref
Crossref
Lisa A. Purcell, Stephanie K. Yanow, Moses Lee, Terry W. Spithill & Ana Rodriguez. (2008) Chemical Attenuation of Plasmodium berghei Sporozoites Induces Sterile Immunity in Mice. Infection and Immunity 76:3, pages 1193-1199.
Crossref
Crossref
T.A. Lang & G.O. Kokwaro. (2008) Malaria drug and vaccine trials in Africa: obstacles and opportunities. Transactions of the Royal Society of Tropical Medicine and Hygiene 102:1, pages 7-10.
Crossref
Crossref
Alan R. Shaw & Mark B. Feinberg. 2008. Clinical Immunology. Clinical Immunology
1353
1382
.
Walter R. Weiss, Anita Kumar, George Jiang, Jackie Williams, Anthony Bostick, Solomon Conteh, David Fryauff, Joao Aguiar, Manmohan Singh, Derek T. O'Hagan, Jeffery B. Ulmer & Thomas L. Richie. (2007) Protection of Rhesus Monkeys by a DNA Prime/Poxvirus Boost Malaria Vaccine Depends on Optimal DNA Priming and Inclusion of Blood Stage Antigens. PLoS ONE 2:10, pages e1063.
Crossref
Crossref
Lynn W. Kitchen & David W. Vaughn. (2007) Role of U.S. military research programs in the development of U.S.-licensed vaccines for naturally occurring infectious diseases. Vaccine 25:41, pages 7017-7030.
Crossref
Crossref
Kent E. Kester, Denise A. McKinney, Nadia Tornieporth, Christian F. Ockenhouse, D. Gray HeppnerJr.Jr., Ted Hall, Bruce T. Wellde, Kate White, Peifang Sun, Robert Schwenk, Urszula Krzych, Martine Delchambre, Gerald Voss, Marie-Claude Dubois, Robert A. GasserJr.Jr., Megan G. Dowler, Megan O?Brien, Janet Wittes, Robert Wirtz, Joe Cohen & W. Ripley Ballou. (2007) A phase I/IIa safety, immunogenicity, and efficacy bridging randomized study of a two-dose regimen of liquid and lyophilized formulations of the candidate malaria vaccine RTS,S/AS02A in malaria-na?ve adults. Vaccine 25:29, pages 5359-5366.
Crossref
Crossref
Mark E. Polhemus, Alan J. Magill, James F. Cummings, Kent E. Kester, Chris F. Ockenhouse, David E. Lanar, Sheetij Dutta, Arnoldo Barbosa, Lorraine Soisson, Carter L. Diggs, Sally A. Robinson, John D. Haynes, V. Ann Stewart, Lisa A. Ware, Clara Brando, Urszula Krzych, Robert A. Bowden, Joe D. Cohen, Marie-Claude Dubois, Opokua Ofori-Anyinam, Els De-Kock, W. Ripley Ballou & D. Gray HeppnerJr.Jr.. (2007) Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research. Vaccine 25:21, pages 4203-4212.
Crossref
Crossref
Clara Brando, Lisa A. Ware, Helen Freyberger, April Kathcart, Arnoldo Barbosa, Sylvie Cayphas, Marie-Ange Demoitie, Pascal Mettens, D. Gray Heppner & David E. Lanar. (2007) Murine Immune Responses to Liver-Stage Antigen 1 Protein FMP011, a Malaria Vaccine Candidate, Delivered with Adjuvant AS01B or AS02A. Infection and Immunity 75:2, pages 838-845.
Crossref
Crossref
Marc P. Girard, Zarifah H. Reed, Martin Friede & Marie Paule Kieny. (2007) A review of human vaccine research and development: Malaria. Vaccine 25:9, pages 1567-1580.
Crossref
Crossref
K.M. Muraleedharan & M.A. Avery. 2007. Comprehensive Medicinal Chemistry II. Comprehensive Medicinal Chemistry II
765
814
.
V. Ann Stewart, Douglas S. Walsh, Shannon M. McGrath, Kent E. Kester, James F. Cummings, Gerald Voss, Martine Delchambre, Nathalie Garçon, Joe D. Cohen & D. Gray HeppnerJr.Jr.. (2006) Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques. Vaccine 24:42-43, pages 6493-6502.
Crossref
Crossref
V. Ann Stewart, Shannon M. McGrath, Douglas S. Walsh, Stacey Davis, Aaron S. Hess, Lisa A. Ware, Kent E. Kester, James F. Cummings, J. Robert Burge, Gerald Voss, Martine Delchambre, Nathalie Garçon, Douglas B. Tang, Joe D. Cohen & D. Gray HeppnerJr.Jr.. (2006) Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A. Vaccine 24:42-43, pages 6483-6492.
Crossref
Crossref
Adrian V. S. Hill. (2005) Pre-erythrocytic malaria vaccines: towards greater efficacy. Nature Reviews Immunology 6:1, pages 21-32.
Crossref
Crossref
Pedro L Alonso, Jahit Sacarlal, John J Aponte, Amanda Leach, Eusebio Macete, Pedro Aide, Betuel Sigauque, Jessica Milman, Inacio Mandomando, Quique Bassat, Caterina Guinovart, Mateu Espasa, Sabine Corachan, Marc Lievens, Margarita M Navia, Marie-Claude Dubois, Clara Menendez, Filip Dubovsky, Joe Cohen, Ricardo Thompson & W Ripley Ballou. (2005) Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial. The Lancet 366:9502, pages 2012-2018.
Crossref
Crossref